• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The metabolism of proinsulin and insulin by the liver.肝脏对胰岛素原和胰岛素的代谢。
J Clin Invest. 1972 Apr;51(4):912-21. doi: 10.1172/JCI106886.
2
Metabolism of proinsulin, insulin, and C-peptide in the rat.大鼠中胰岛素原、胰岛素和C肽的代谢
J Clin Invest. 1973 May;52(5):1113-21. doi: 10.1172/JCI107277.
3
Insulin removal by isolated perfused rat liver.通过离体灌注大鼠肝脏去除胰岛素。
Am J Physiol. 1976 Jan;230(1):171-7. doi: 10.1152/ajplegacy.1976.230.1.171.
4
Kinetics of circulating endogenous insulin, C-peptide, and proinsulin in fasting nondiabetic man.空腹非糖尿病男性体内循环内源性胰岛素、C肽和胰岛素原的动力学
Metabolism. 1987 May;36(5):463-8. doi: 10.1016/0026-0495(87)90044-8.
5
Retention and degradation of 125I-insulin by perfused livers from diabetic rats.糖尿病大鼠灌注肝脏对¹²⁵I-胰岛素的摄取与降解
J Clin Invest. 1976 Apr;57(4):885-96. doi: 10.1172/JCI108365.
6
[Insulin and proinsulin degradation normally and in experimental diabetes].[胰岛素和胰岛素原在正常及实验性糖尿病状态下的降解]
Probl Endokrinol (Mosk). 1979 Mar-Apr;25(2):57-61.
7
Endocytotic uptake, processing, and retroendocytosis of human biosynthetic proinsulin by rat fibroblasts transfected with the human insulin receptor gene.用人胰岛素受体基因转染的大鼠成纤维细胞对人生物合成胰岛素原的内吞摄取、加工及逆向内吞作用
J Clin Invest. 1988 May;81(5):1370-7. doi: 10.1172/JCI113465.
8
Differential rates of conversion of rat proinsulins I and II. Evidence for slow cleavage at the B-chain/C-peptide junction of proinsulin II.大鼠胰岛素原I和II的不同转化速率。胰岛素原II的B链/C肽连接处存在缓慢切割的证据。
Biochem J. 1991 Sep 15;278 ( Pt 3)(Pt 3):621-5. doi: 10.1042/bj2780621.
9
Cell itinerary and metabolic fate of proinsulin in rat liver: in vivo and in vitro studies.大鼠肝脏中胰岛素原的细胞行程与代谢命运:体内与体外研究
Endocrinology. 2003 Dec;144(12):5308-21. doi: 10.1210/en.2002-0154. Epub 2003 Sep 11.
10
Clearance of immunoreactive somatostatin by perfused rat liver.灌注大鼠肝脏对免疫反应性生长抑素的清除作用。
J Clin Invest. 1981 Feb;67(2):419-29. doi: 10.1172/JCI110050.

引用本文的文献

1
Characterization of impaired beta and alpha cell function in response to an oral glucose challenge in cystic fibrosis: a cross-sectional study.囊性纤维化患者口服葡萄糖挑战后β和α细胞功能受损的特征:一项横断面研究。
Front Endocrinol (Lausanne). 2023 Aug 31;14:1249876. doi: 10.3389/fendo.2023.1249876. eCollection 2023.
2
Understanding Insulin in the Age of Precision Medicine and Big Data: Under-Explored Nature of Genomics.精准医学和大数据时代的胰岛素认识:基因组学的未探索本质。
Biomolecules. 2023 Jan 30;13(2):257. doi: 10.3390/biom13020257.
3
Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population.空腹胰岛素原可独立预测普通人群中2型糖尿病的发病情况。
J Pers Med. 2022 Jul 12;12(7):1131. doi: 10.3390/jpm12071131.
4
FADD Phosphorylation Modulates Blood Glucose Levels by Decreasing the Expression of Insulin-Degrading Enzyme.FADD 磷酸化通过降低胰岛素降解酶的表达来调节血糖水平。
Mol Cells. 2020 Apr 30;43(4):373-383. doi: 10.14348/molcells.2020.2198.
5
Gluco-metabolic effects of oral and intravenous alcohol administration in men.男性口服和静脉注射酒精的糖代谢效应
Endocr Connect. 2019 Oct;8(10):1372-1382. doi: 10.1530/EC-19-0317.
6
Favorable glycemic response after pancreatoduodenectomy in both patients with pancreatic cancer and patients with non-pancreatic cancer.胰腺癌患者和非胰腺癌患者在胰十二指肠切除术后均有良好的血糖反应。
Medicine (Baltimore). 2018 May;97(18):e0590. doi: 10.1097/MD.0000000000010590.
7
Elevations in the Fasting Serum Proinsulin-to-C-Peptide Ratio Precede the Onset of Type 1 Diabetes.空腹血清胰岛素原与C肽比值升高先于1型糖尿病发病。
Diabetes Care. 2016 Sep;39(9):1519-26. doi: 10.2337/dc15-2849. Epub 2016 Jul 6.
8
Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance.高胰岛素血症与多囊卵巢综合征(PCOS):胰岛素清除的作用
J Endocrinol Invest. 2015 Dec;38(12):1319-26. doi: 10.1007/s40618-015-0372-x. Epub 2015 Aug 21.
9
Zinc transport and diabetes risk.锌转运与糖尿病风险。
Nat Genet. 2014 Apr;46(4):323-4. doi: 10.1038/ng.2934.
10
Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults.空腹血清 C 肽水平可预测非糖尿病成年人的心血管和全因死亡。
J Am Heart Assoc. 2012 Dec;1(6):e003152. doi: 10.1161/JAHA.112.003152. Epub 2012 Dec 19.

本文引用的文献

1
Preparation of iodine-131 labelled human growth hormone of high specific activity.高比活度碘-131标记人生长激素的制备
Nature. 1962 May 5;194:495-6. doi: 10.1038/194495a0.
2
FATE OF RAT INSULIN IN RAT-LIVER PERFUSION STUDIED BY ADIPOSE-TISSUE ASSAY.通过脂肪组织测定法研究大鼠肝脏灌流中大鼠胰岛素的去向
Lancet. 1963 Aug 17;2(7303):314-6. doi: 10.1016/s0140-6736(63)92987-8.
3
The isolation of insulin from a single cat pancreas.从一只猫的胰腺中分离胰岛素。
Biochim Biophys Acta. 1962 Sep 10;63:150-3. doi: 10.1016/0006-3002(62)90347-5.
4
Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase, glutamic-pyruvic transaminase, and lactic acid dehydrogenase.用于测定谷草转氨酶、谷丙转氨酶和乳酸脱氢酶的改良分光光度法。
Am J Clin Pathol. 1960 Oct;34:381-98. doi: 10.1093/ajcp/34.4_ts.381.
5
Metabolism of insulin-I 131; studies in isolated, perfused rat liver and hindlimb preparations.胰岛素-I 131的代谢;在离体灌注大鼠肝脏和后肢制剂中的研究。
Diabetes. 1959 Jul-Aug;8(4):307-14. doi: 10.2337/diab.8.4.307.
6
Studies on the specificity of an insulin-inactivating system of the liver.肝脏胰岛素失活系统的特异性研究。
J Biol Chem. 1955 Dec;217(2):685-94.
7
Clearance studies of insulin and nonsuppressible insulin-like activity (NSILA) in the rat liver.大鼠肝脏中胰岛素及非抑制性胰岛素样活性(NSILA)的清除率研究。
Proc Soc Exp Biol Med. 1967 Oct;126(1):166-9. doi: 10.3181/00379727-126-32392.
8
Analysis of urinary excretion of insulin in the normal dog.正常犬胰岛素尿排泄分析
Arch Int Pharmacodyn Ther. 1967 Jun;167(2):480-2.
9
Control of gluconeogenesis in liver. I. General features of gluconeogenesis in the perfused livers of rats.肝脏中糖异生的调控。I. 大鼠灌注肝脏中糖异生的一般特征。
J Biol Chem. 1967 Jun 10;242(11):2622-36.
10
Effects of stimulation of the vagus nerve on insulin secretion.刺激迷走神经对胰岛素分泌的影响。
Endocrinology. 1967 Mar;80(3):530-6. doi: 10.1210/endo-80-3-530.

肝脏对胰岛素原和胰岛素的代谢。

The metabolism of proinsulin and insulin by the liver.

作者信息

Rubenstein A H, Pottenger L A, Mako M, Getz G S, Steiner D F

出版信息

J Clin Invest. 1972 Apr;51(4):912-21. doi: 10.1172/JCI106886.

DOI:10.1172/JCI106886
PMID:5014618
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC302205/
Abstract

The removal of bovine proinsulin by the isolated perfused rat liver has been studied and the results compared with the removal of insulin. At high concentrations of insulin (> 180 ng/ml) the removal process was saturated and the t(1/2) varied between 35 and 56 min. With low initial insulin levels the disappearance followed first-order kinetics, the mean regression coefficient being - 0.022, t(1/2) 13.8 min, and the hepatic extraction 4.0 ml/min. The results with proinsulin were in striking contrast to these findings. At both high and low concentrations the hepatic removal of proinsulin was considerably slower, averaging 10-15 times less than that of insulin. Specific immunoassay techniques and gel filtration of samples taken from perfusions to which both labeled and unlabeled proinsulin had been added did not show conversion to either insulin or the C-peptide. Bovine and rat (131)I-labeled proinsulins were degraded more slowly than bovine insulin-(131)I by bovine and rat liver homogenates. Both proinsulin and insulin inhibited the degradation of insulin-(131)I, equimolar quantities of proinsulin being 2-5 times less effective than insulin. These results indicate significant differences in the capacity of the liver to remove and degrade insulin and proinsulin. The low hepatic extraction of proinsulin may account for its prolonged half-life in vivo and contribute to its relatively high plasma concentration in the fasting state. Furthermore this finding will have to be taken into account in the interpretation of changes in the proinsulin:insulin ratios in peripheral blood in a variety of metabolich situations.

摘要

已对离体灌注大鼠肝脏对牛胰岛素原的清除进行了研究,并将结果与胰岛素的清除情况进行了比较。在高浓度胰岛素(>180 ng/ml)时,清除过程达到饱和,半衰期在35至56分钟之间变化。当初始胰岛素水平较低时,其消失遵循一级动力学,平均回归系数为-0.022,半衰期为13.8分钟,肝脏提取率为4.0 ml/分钟。胰岛素原的结果与这些发现形成了鲜明对比。在高浓度和低浓度下,肝脏对胰岛素原的清除都要慢得多,平均比胰岛素少10至15倍。采用特异性免疫测定技术以及对添加了标记和未标记胰岛素原的灌注样本进行凝胶过滤,均未显示胰岛素原转化为胰岛素或C肽。牛和大鼠的(131)I标记胰岛素原比牛胰岛素-(131)I被牛和大鼠肝脏匀浆降解得更慢。胰岛素原和胰岛素均抑制胰岛素-(131)I的降解,等摩尔量的胰岛素原的效力比胰岛素低2至5倍。这些结果表明肝脏在清除和降解胰岛素及胰岛素原的能力上存在显著差异。肝脏对胰岛素原的低提取率可能解释了其在体内较长的半衰期,并导致其在空腹状态下血浆浓度相对较高。此外,在解释各种代谢情况下外周血中胰岛素原:胰岛素比值的变化时,必须考虑到这一发现。